drugset
drugset / Trial / NCT01429818

Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients

NCT01429818 ↗

Phase 4 Completed 16 enrolled Laboratorios Silanes S.A. de C.V.
RandomizedParallel-groupDouble-blindTreatment

Summary

The Purpose of this study was to evaluate the effect of the combination glimepiride/metformin over endothelial dysfunction (ED) in asymptomatic patients with type 2 diabetes mellitus (DM) using 13N-ammonia-positron emission tomography (PET).

Timeline

Start
2007-07
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Glimepiride Small molecule 4 mg —
Comparator Metformin Small molecule 1000 mg —

Indications

type 2 diabetes mellitus